K
Karl E. Anderson
Researcher at University of Texas Medical Branch
Publications - 210
Citations - 9803
Karl E. Anderson is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Porphyria & Acute intermittent porphyria. The author has an hindex of 54, co-authored 199 publications receiving 8900 citations. Previous affiliations of Karl E. Anderson include Rutgers University & Yeshiva University.
Papers
More filters
Journal ArticleDOI
Defining translational research: implications for training.
Doris M. Rubio,Ellie E. Schoenbaum,Linda S. Lee,David E. Schteingart,Paul R. Marantz,Karl E. Anderson,Lauren Dewey Platt,Adriana Baez,Karin Esposito +8 more
TL;DR: The authors argue that the approach to designing and evaluating the success of translational training programs must be flexible enough to accommodate the needs of individual institutions and individual trainees within the institutions but that it must also be rigorous enough to document that the program is meeting its short-, intermediate-, and long-term objectives and that its trainees are meeting preestablished competency requirements.
Journal ArticleDOI
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Karl E. Anderson,Joseph R. Bloomer,Herbert L. Bonkovsky,James P. Kushner,Claus A. Pierach,Neville R. Pimstone,Robert J. Desnick +6 more
TL;DR: The panel, which represents specialties including internal medicine, pediatrics, genetics, gastroenterology, hepatology, and hematology, was charged with formulating updated recommendations for diagnosing and treating the acute porphyrias, issued recommendations based on the specific enzyme and gene defects identified.
Journal ArticleDOI
Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis.
TL;DR: The disease is usually classified as sporadic if uroporphyrinogen decarboxylase is deficient only in the liver, and as familial (autosomal dominant) if the enzyme is also deficient in nonhepatic tissues such as erythrocytes.
Journal ArticleDOI
Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man
TL;DR: Significant influences of nutritional factors on oxidative biotransformation of drugs in man are demonstrated, particularly when the subjects were placed on standard diets followed by the standard diets supplemented with carbohydrate or protein.
Journal ArticleDOI
Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria
Manisha Balwani,Eliane Sardh,Paolo Ventura,Paula Aguilera Peiró,David C. Rees,Ulrich Stölzel,D. Montgomery Bissell,Herbert L. Bonkovsky,Jerzy Windyga,Karl E. Anderson,Charles J. Parker,Samuel M. Silver,Sioban Keel,Jiaan-Der Wang,Penelope E. Stein,Pauline Harper,Daphne Vassiliou,Bruce Wang,John D. Phillips,Aneta Ivanova,Janneke G. Langendonk,Raili Kauppinen,Elisabeth I. Minder,Yutaka Horie,Craig Penz,Jihong Chen,Shangbin Liu,John J. Ko,Marianne T. Sweetser,Pushkal Garg,Akshay Vaishnaw,Jae B. Kim,Amy Simon,Laurent Gouya,Envision Investigators +34 more
TL;DR: Givosiran led to lower levels of urinary ALA and porphobilinogen, fewer days of hemin use, and better daily scores for pain than placebo, and the increased efficacy was accompanied by a higher frequency of hepatic and renal adverse events.